Pres. Duterte Tells China Ambassador To Withdraw All Sinopharm Vaccines
DUTERTE – Philippine Pres. Rodrigo Roa Duterte told the envoy of China to send Sinovac COVID-19 vaccines to PH and not Sinopharm.
In the pursuit to put an end to the spread of the COVID-19 virus, most nations and territories now are vaccinating its citizens to achieve the herd immunity. There are different coronavirus vaccines developed by different nations and firms.
Among the vaccines that have reached the Philippines are AstraZeneca, Russia’s Sputnik V, and China’s Sinopharm and Sinovac. The country is currently dealing with a tougher battle against the spread of the disease.
The total COVID-19 cases in the Philippines now has went beyond the 1-million mark. Every day for weeks now, the country is logging at least 8,000 new cases of the disease.
Recently, Sinovac COVID-19 vaccines that were made by a Chinese firm arrived in the Philippines. Based on a report on ABS-CBN News, there were 1,000 doses of the said vaccine.
Pres. Rodrigo Roa Duterte received a Sinovac jab. The members of the Presidential Security Group (PSG) also got the said COVID-19 but, reportedly, it still did not have the clearance from the Philippine drug regulator for emergency use.
Based on the report, Pres. Duterte said that he already told the envoy of China in the Philippines to send the country Sinovac COVID-19 vaccines and not Sinopharm. Also, the 1,000 doses sent in PH would be recalled.
“Huwag ka na lang magpadala ng Sinopharm dito para walang gulo. Sabi ko, ibigay mo lang sa amin ‘yong Sinovac na ginagamit sa lahat,” the President said referring to his message to Chinese Ambassador to the Philippines Huang Xilian.
The Chief Executive assured that the 1,000 doses that will recalled “would not make a dent” on the supply of the vaccines. The Sinovac has an emergency use authorization in the country while the Sinopharm only has a “compassionate use license” for the President’s security team.
Thank you for visiting Philnews.ph. You may express your thoughts and reactions below through the comment section. You may also follow us on Facebook, on Twitter, and subscribe to our YouTube channel Philnews Ph.